# Nuclide record nct07129252 (trial). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/trials/nct07129252/>
  a schema:MedicalTrial ;
  nuclide:kind "trial" ;
  schema:identifier "nct07129252", "NCT07129252" ;
  schema:name "A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors"@en ;
  schema:alternateName "BRAVESST2"@en ;
  schema:description "A phase 1/2 trial of CRN09682 in neuroendocrine tumours, run by Crinetics Pharmaceuticals Inc., now recruiting."@en ;
  schema:url <https://nuclide.cc/trials/nct07129252/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07129252> ;
  nuclide:status "recruiting" ;
  nuclide:tag "pipeline", "ctgov-ingest" ;
  nuclide:phase "1/2" ;
  nuclide:indications <https://nuclide.cc/indications/neuroendocrine/> .